| Literature DB >> 26288557 |
Mohamed A Dkhil1, Saleh Al-Quraishy2, Ahmed Al-Shamrany2, Ahmed S Alazzouni3, Mahmoud Y Lubbad4, Esam M Al-Shaebi2, Noory T Taib2.
Abstract
The present study aimed to investigate the protective role of berberine (BER) against Plasmodium chabaudi-induced infection in mice. Animals were divided into three groups. Group I served as a vehicle control. Group II and group III were infected with 1000 P. chabaudi infected erythrocytes. Group III was gavaged with 100 μl of 10 mg/kg berberine chloride for 10 days. All mice were sacrificed at day 10 post-infection. The percentage of parasitemia was significantly reduced more than 30%, after treatment of mice with BER. Infection caused marked hepatic injuries as indicated by histopathological alterations as evidenced by the presence of hepatic lobular inflammatory cellular infiltrations, dilated sinusoids, vacuolated hepatocytes, increased number of Kupffer cells and the malaria pigment, hemozoin. These changes in livers led to the increased histological score. Also, infection induced a significant increase in liver alanine aminotransferase and aspartate aminotransferase and a significant increase in the total leucocytic count. Moreover, mice became anemic as proved by the significant decrease in erythrocyte number and haemoglobin content. BER showed a significant protective potential by improving the above mentioned parameters. Based on these results, it is concluded that berberine could offer protection against hepatic tissue damage.Entities:
Keywords: Berberine; Liver; Mice; Plasmodium chabaudi
Year: 2014 PMID: 26288557 PMCID: PMC4537865 DOI: 10.1016/j.sjbs.2014.11.023
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
Figure 1Berberine lowers the percentage of parasitemia at day 10 p.i. with P. chabaudi-parasitized erythrocytes. Values are means ± SD. ∗P ⩽ 0.05, significant against the non-infected group.
Figure 2Berberine improved hepatic histopathological changes induced by P. chabaudi-parasitized erythrocytes. (A,B) Non-infected liver with normal architecture. (C,D) Infected liver at day 10 p.i.. Pathological changes consist of necro-inflammatory changes dominated by lymphocytes (star), Plasmodium-infected erythrocytes, apoptotic bodies (black arrow), hemozoin (white arrow head) in Kupffer cells and P. chabaudi-parasitized erythrocytes attached to Kupffer cell. (E,F) Infected-treated mice with berberine. Liver appeared with less lesion and improved tissue damage. Sections are stained with hematoxylin and eosin. Bar = 25 μm.
Berberine induced histopathological changes in liver of mice infected with P. chabaudi-parasitized erythrocytes.
| Group | Histological activity index | Microscopic observation | |||||
|---|---|---|---|---|---|---|---|
| Necrosis or apoptosis | Hemorrhage | Disorganized sinusoids | Infiltration of lymphocytes | Hyperplasia of Kupffer cells | Hepatocytic swelling | ||
| Non-infected | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Infected (−berberine) | 13–15 | ++ | +++ | + | +++ | ++ | ++ |
| Infected (+berberine) | 6–8 | + | + | + | + | ++ | + |
Modified according to Ishak et al. (1995). Score: 1–3, minimal; 4–8, mild; 9–12, moderate; 13–18. Severe: 0: absent; +: mild; ++; moderate; and +++: severe.
Changes in leucocyte count, erythrocyte count and haemoglobin due to berberine treatment of mice infected with P. chabaudi infected erythrocytes.
| Parameter | Non-infected | Infected (−berberine) | Infected (+berberine) |
|---|---|---|---|
| Leucocytes × 103/mm3 | 6.4 ± 1 | 9.5 ± 3.5 | 6.5 ± 3.4 |
| Erythrocytes × 106/mm3 | 7.9 ± 2 | 6.1 ± 0.7 | 8.5 ± 1.7 |
| Haemoglobin (g/dL) | 14.5 ± 3.4 | 9.4 ± 2.4 | 13.4 ± 0.7 |
Values are means ± SD.
Significant change at P ⩽ 0.05 with respect to control non-infected mice.
Significant change at P ⩽ 0.05 between infected mice (−berberine) and infected mice (+berberine).
Changes in ALT, AST and ALP due to berberine treatment of mice infected with P. chabaudi infected erythrocytes.
| Parameter | Non-infected | Infected (−berberine) | Infected (+berberine) |
|---|---|---|---|
| ALT (U/L) | 58.5 ± 4 | 115 ± 23 | 93 ± 11 |
| AST (U/L) | 210 ± 30 | 396 ± 18 | 269 ± 63 |
| ALP (U/L) | 132 ± 48 | 90 ± 26 | 100 ± 42 |
Values are means ± SD.
Significant change at P ⩽ 0.05 with respect to control non-infected mice.
Significant change at P ⩽ 0.05 between infected mice (−berberine) and infected mice (+berberine).